🇺🇸 FDA
Pipeline program

bilateral permanent occlusion of uterine arteries

Adelhelal

Phase 2 other completed

Quick answer

bilateral permanent occlusion of uterine arteries for Other Abnormal Uterine and Vaginal Bleeding is a Phase 2 program (other) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
Other Abnormal Uterine and Vaginal Bleeding
Phase
Phase 2
Modality
other
Status
completed

Clinical trials